⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting
globenewswire.com
ABBV
Fill Finish Manufacturing Market Analysis Report 2026-2035: A $21+ Billion Market by 2030 with Johnson & Johnson, AbbVie, Thermo Fisher Scientific, BD & Co, Baxter, Lonza, and Catalent Leading
globenewswire.com
JNJ
ABBV
TMO
BDX
BAX
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven by Digital Insulin Pens and Pumps Transforming Diabetes Care, Says a 2026 Mordor Intelligence Report
prnewswire.com
BSX
ABT
MDT
CAH
REGN
ABBV
U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
prnewswire.com
ABBV
Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
prnewswire.com
ABBV
QTTB
HCWB
NKTR
LLY
INCY
PFE
Cancer & Antibody Conjugates Patent Landscape Analysis 2025: 3761 Patent Families - IP Trends, Including Time Evolution of Published Patents and Countries of Patent Filings
globenewswire.com
PFE
BMY
ABBV
AZN
GILD
AbbVie Declares Quarterly Dividend
prnewswire.com
ABBV
FNIH Biomarkers Consortium Study Shows “Clock Model” Blood Test Can Predict Onset of Alzheimer’s Symptoms Years in Advance
businesswire.com
ABBV
JNJ
BIIB
JAK Inhibitors Competitive Landscape Report 2026: Comprehensive Insights on 40+ Companies and 45+ Drugs by Company, Product Type, Development Stage, Administration Route, Molecule Type
globenewswire.com
LLY
ABBV
INCY
Juvenile Idiopathic Arthritis Market is Expected to Expand at a Healthy Growth Rate of 5.6% During the Forecast Period (2026-2036) | DelveInsight
prnewswire.com
BMY
ABBV
REGN
LLY
PFE